Are a high-refined carbohydrate diet and the alterations resulting from its intake linked to small intestine changes?

FHS
June 27, 2023
10:02 am

Researchers investigated whether a high-refined carbohydrate diet and associated metabolic alterations could cause small intestinal dysregulation.

Alnylam plans to appeal Covid-19 vaccine patent ruling in case against Moderna

Alnylam agreed to a final judgment that Moderna did not infringe on two of Alnylam’s patents, though the company said Friday it plans to appeal

August 29, 2023

Social media algorithms are driving the GLP-1 drugs boom – Pharmaceutical Technology

GLP-1 RA drugs are prescribed as treatments for patients with type 2 diabetes, or obesity. Credit: UCG / Getty. A rapid growth in demand for

October 3, 2024

FDA extends pandemic-era policy allowing certain device, production changes without prior approval

Dive Brief: The Food and Drug Administration will continue to allow medical device manufacturers to make alterations to certain products or manufacturing processes without prior

November 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.